Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters

Open Access

Peer-reviewed

Research Article

Walid Fayad,

Affiliation Department of Oncology and Pathology, Karolinska Institute and Hospital, Stockholm, Sweden
⨯
Mårten Fryknäs,

Affiliation Department of Medical Sciences, Division of Clinical Pharmacology, University Hospital, Uppsala University, Uppsala, Sweden
⨯
Slavica Brnjic,

Affiliation Department of Oncology and Pathology, Karolinska Institute and Hospital, Stockholm, Sweden
⨯
Maria Hägg Olofsson,

Affiliation Department of Oncology and Pathology, Karolinska Institute and Hospital, Stockholm, Sweden
⨯
Rolf Larsson,

Affiliation Department of Medical Sciences, Division of Clinical Pharmacology, University Hospital, Uppsala University, Uppsala, Sweden
⨯
Stig Linder

* E-mail: Stig.Linder@ki.se

Affiliation Department of Oncology and Pathology, Karolinska Institute and Hospital, Stockholm, Sweden
⨯

Reader Comments (0)

Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Mitochondria
Is the Subject Area "Mitochondria" applicable to this article?

Thanks for your feedback.
Carcinoma
Is the Subject Area "Carcinoma" applicable to this article?

Thanks for your feedback.
Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.